Revlon credit
This article was originally published in The Rose Sheet
Executive Summary
Amendment to firm's credit facility, approved unanimously by bank group, includes one-year extension of the waiver to EBITDA and other financial covenants received by Revlon last year under the credit agreement, company announces Jan. 29. Amendment reflects "continued support of the company's progress against its growth plan," Revlon states. Under the amendment, company's financial covenants have been waived for the four fiscal quarters ending Dec. 31, 2003, eliminated for the first three quarters of 2004 and waived through Jan. 31, 2005 for the four fiscal quarters ending Dec. 31, 2004. It also continues the $20 mil. minimum liquidity covenant established with the 2003 credit agreement and extends the $65 mil. line of credit provided by MacAndrews & Forbes from Dec. 1, 2005 to June 30, 2005. Interest rate for loans under the agreement will increase by .25%...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.